May 2003
Volume 44, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2003
Posterior Sub-Tenon's Injection of Triamcinolone in the Treatment of CME Associated With Retinal Vein Occlusion
Author Affiliations & Notes
  • N. Terauchi
    Ophthalmology, Keio University School of Medicine, Tokyo, Japan
  • H. Shinoda
    Ophthalmology, Keio University School of Medicine, Tokyo, Japan
  • K. Shinoda
    Ophthalmology, Keio University School of Medicine, Tokyo, Japan
  • N. Nagai
    Ophthalmology, Keio University School of Medicine, Tokyo, Japan
  • M. Inoue
    Ophthalmology, Keio University School of Medicine, Tokyo, Japan
  • Footnotes
    Commercial Relationships  N. Terauchi, None; H. Shinoda, None; K. Shinoda, None; N. Nagai, None; M. Inoue, None.
Investigative Ophthalmology & Visual Science May 2003, Vol.44, 1882. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      N. Terauchi, H. Shinoda, K. Shinoda, N. Nagai, M. Inoue; Posterior Sub-Tenon's Injection of Triamcinolone in the Treatment of CME Associated With Retinal Vein Occlusion . Invest. Ophthalmol. Vis. Sci. 2003;44(13):1882.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose:To investigate the efficacy of posterior sub-Tenon’s injection of triamcinolone in the treatment of cystoid macular edema (CME) associated with retinal vein occlusion. Methods: Five eyes of 5 patients (4 men and 1 woman; age ranged from 50 through 71 years old) who were diagnosed with CME were given sub-Tenon’s injectoins of triamcinolone (10 mg). The central macular thickness measured by optical coherence tomography (OCT) and visual acuities were analyzed during prospective follow up. Results: The average decrease of central macular thickness of 5 eyes was 75.7% after 1 month, 68.9% after 2 months, while the central macular thickness began to increase after 3 months. After 2 months , the improvement of visual acuity (≥2 Snellen lines) was seen in 2 eyes (40%) with posterior vitreous detachment (PVD). In 1 eye, remarkable improvement was obtained to 20/20 from 20/50. Visual acuity did not improved in 3 eyes without PVD, while the retinal thickness decreased. Conclusions: Posterior sub-Tenon’s injection of triamcinolone could be effective in the treatment of CME associated with retinal vein occlusion.

Keywords: vascular occlusion/vascular occlusive disease • drug toxicity/drug effects • macula/fovea 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×